[
  {
    "ts": null,
    "headline": "Humana Inc. stock outperforms competitors despite losses on the day",
    "summary": "Humana Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=74230f762f5e30219c6626ed7f915c3e1e721d988e390ec67be2d4304a557615",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753981020,
      "headline": "Humana Inc. stock outperforms competitors despite losses on the day",
      "id": 136177403,
      "image": "",
      "related": "HUM",
      "source": "MarketWatch",
      "summary": "Humana Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=74230f762f5e30219c6626ed7f915c3e1e721d988e390ec67be2d4304a557615"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Stock Surges on Earnings Beat and Guidance Raise",
    "summary": "The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.",
    "url": "https://finnhub.io/api/news?id=042f0a576a461ff8696074c012d26b6ca9096448c4af30971c5b7174a4d763dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753960680,
      "headline": "CVS Health Stock Surges on Earnings Beat and Guidance Raise",
      "id": 136151831,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.",
      "url": "https://finnhub.io/api/news?id=042f0a576a461ff8696074c012d26b6ca9096448c4af30971c5b7174a4d763dd"
    }
  },
  {
    "ts": null,
    "headline": "Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test",
    "summary": "MADISON, Wis., July 31, 2025--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance access to colorectal cancer (CRC) screening.",
    "url": "https://finnhub.io/api/news?id=5765c205c8523c28a47943cdda5c363b050bdda54ac2b5dfec076cb816d897b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753959600,
      "headline": "Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test",
      "id": 136152149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "MADISON, Wis., July 31, 2025--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance access to colorectal cancer (CRC) screening.",
      "url": "https://finnhub.io/api/news?id=5765c205c8523c28a47943cdda5c363b050bdda54ac2b5dfec076cb816d897b7"
    }
  },
  {
    "ts": null,
    "headline": "CVS Shows Signs of Recovery, Beats Wall Street Expectations",
    "summary": "The healthcare giant’s results underscore a split among insurers between those that are struggling and those that are beginning to revive.",
    "url": "https://finnhub.io/api/news?id=d8e899391c16c925c66f4e831ed68d416c5f50fd5757e6b29f47b4b72cfa6b9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753957800,
      "headline": "CVS Shows Signs of Recovery, Beats Wall Street Expectations",
      "id": 136151834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "The healthcare giant’s results underscore a split among insurers between those that are struggling and those that are beginning to revive.",
      "url": "https://finnhub.io/api/news?id=d8e899391c16c925c66f4e831ed68d416c5f50fd5757e6b29f47b4b72cfa6b9d"
    }
  },
  {
    "ts": null,
    "headline": "Humana (HUM) Jumps 12.4% on Higher Revenues, Growth Outlook",
    "summary": "We recently published 10 Stocks With Shocking Surges. Humana Inc. (NYSE:HUM) is one of the best-performing stocks on Wednesday. Humana Inc. extended its rally for a second day on Wednesday, jumping 12.40 percent to close at $261.47 apiece as investor sentiment was bolstered by higher revenues and growth outlook for the rest of the year. In […]",
    "url": "https://finnhub.io/api/news?id=24af59e2417bee7fc52a1b030761259c8e5155513862a417ec89fc7412ac11cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753956366,
      "headline": "Humana (HUM) Jumps 12.4% on Higher Revenues, Growth Outlook",
      "id": 136152152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "We recently published 10 Stocks With Shocking Surges. Humana Inc. (NYSE:HUM) is one of the best-performing stocks on Wednesday. Humana Inc. extended its rally for a second day on Wednesday, jumping 12.40 percent to close at $261.47 apiece as investor sentiment was bolstered by higher revenues and growth outlook for the rest of the year. In […]",
      "url": "https://finnhub.io/api/news?id=24af59e2417bee7fc52a1b030761259c8e5155513862a417ec89fc7412ac11cd"
    }
  }
]